trending Market Intelligence /marketintelligence/en/news-insights/trending/aos00r9c7h7cdkmv39mqnw2 content esgSubNav
In This List

Voyager Therapeutics CEO to depart

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Voyager Therapeutics CEO to depart

Voyager Therapeutics Inc. said Steven Paul will step down from the positions of president and CEO to become executive science adviser.

Paul is a founder of Voyager, initially serving as president of R&D and later as president and CEO since September 2014. He will continue to serve as CEO while the board searches for his replacement.

The developer of gene therapy added that Paul will continue to serve on the board.